These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22095574)

  • 21. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
    Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
    FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma.
    Yang QC; Zeng BF; Shi ZM; Dong Y; Jiang ZM; Huang J; Lv YM; Yang CX; Liu YW
    J Exp Clin Cancer Res; 2006 Dec; 25(4):593-9. PubMed ID: 17310851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
    Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
    Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF Silencing Inhibits Human Osteosarcoma Angiogenesis and Promotes Cell Apoptosis via PI3K/AKT Signaling Pathway.
    Zhao J; Zhang ZR; Zhao N; Ma BA; Fan QY
    Cell Biochem Biophys; 2015 Nov; 73(2):519-525. PubMed ID: 27352347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice.
    Basciani S; Mariani S; Arizzi M; Brama M; Ricci A; Betsholtz C; Bondjers C; Ricci G; Catizone A; Galdieri M; Spera G; Gnessi L
    Biol Reprod; 2004 Jan; 70(1):168-77. PubMed ID: 14522834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma.
    Sulzbacher I; Träxler M; Mosberger I; Lang S; Chott A
    Mod Pathol; 2000 Jun; 13(6):632-7. PubMed ID: 10874667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival.
    Kiriakidis S; Henze AT; Kruszynska-Ziaja I; Skobridis K; Theodorou V; Paleolog EM; Mazzone M
    FASEB J; 2015 Jul; 29(7):2814-27. PubMed ID: 25837583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H; Fredriksson L; Li X; Eriksson U
    Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
    McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
    J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PHD4 stimulates tumor angiogenesis in osteosarcoma cells via TGF-α.
    Klotzsche-von Ameln A; Prade I; Grosser M; Kettelhake A; Rezaei M; Chavakis T; Flamme I; Wielockx B; Breier G
    Mol Cancer Res; 2013 Nov; 11(11):1337-48. PubMed ID: 24048703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
    Liu JF; Tsao YT; Hou CH
    Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors.
    Cao R; Bråkenhielm E; Li X; Pietras K; Widenfalk J; Ostman A; Eriksson U; Cao Y
    FASEB J; 2002 Oct; 16(12):1575-83. PubMed ID: 12374780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth.
    Huang W; Fridman Y; Bonfil RD; Ustach CV; Conley-LaComb MK; Wiesner C; Saliganan A; Cher ML; Kim HR
    Oncogene; 2012 Oct; 31(42):4527-35. PubMed ID: 22158043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts.
    Seikrit C; Henkel C; van Roeyen CR; Bokemeyer D; Eitner F; Martin IV; Boor P; Knüchel R; Meyer HE; Müller-Newen G; Eriksson U; Floege J; Ostendorf T
    Nephrol Dial Transplant; 2013 Apr; 28(4):889-900. PubMed ID: 23229927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy.
    Tanaka T; Yui Y; Naka N; Wakamatsu T; Yoshioka K; Araki N; Yoshikawa H; Itoh K
    Clin Exp Metastasis; 2013 Apr; 30(4):369-79. PubMed ID: 23076771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
    Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
    Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
    Xu L; Tong R; Cochran DM; Jain RK
    Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a plasmid for expression of rat platelet-derived growth factor C and its effects on proliferation, migration and adhesion of endothelial progenitor cells.
    Tang B; Gong JP; Sun JM; Luo WJ; Chen YK; Liu ZJ; Li F; Fu J
    Plasmid; 2013 May; 69(3):195-201. PubMed ID: 22935743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived growth factor (PDGF) and PDGF receptor expression and function in folliculostellate pituitary cells.
    Kowarik M; Onofri C; Colaco T; Stalla GK; Renner U
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):113-20. PubMed ID: 19373754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor suppressive effect of angiotensin II type 1 receptor antagonist in a murine osteosarcoma model.
    Wasa J; Sugiura H; Kozawa E; Kohyama K; Yamada K; Taguchi O
    Anticancer Res; 2011 Jan; 31(1):123-7. PubMed ID: 21273589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.